Sign up to see all 5.
Sign up to see all 4.
No insider has filed a notice of proposed sale (Form 144) for IN8BIO, INC. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
AI
Alyeska Investment Group, L.P.
|
944.3K | 4.85% | Unchanged | 2023 | 0.0% | |
|
Shares held by quarter
Peak holding5.1M (Q4'24)
Change over 8 quarters+509.5K
Share of the company4.850%
|
||||||
|
FR
Franklin Resources Inc
|
914.5K | 4.70% | Unchanged | 2024 | 0.0% | |
|
Shares held by quarter
Peak holding5.7M (Q4'24)
Change over 8 quarters+914.5K
Share of the company4.700%
|
||||||
20 more super investors behind a free account
See every manager holding IN8BIO, INC., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FB
Franklin Strategic Series
|
$345K | 332.1K | 1.71% | 0.03% | July 31, 2026 |
|
VE
Vanguard Index Funds
|
$125K | 88.9K | 0.46% | 0.00% | June 30, 2026 |
6 more funds behind a free account
See every fund holding IN8BIO, INC. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
FA
Fletcher Aaron G.L.
5%+ holder
13D · 4.0%
|
391.4K | 2.01% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
BA
BIOS Advisors GP, LLC
5%+ holder
13D · 4.0%
|
391.4K | 2.01% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
20 more holders behind a free account
See every insider and 5%+ holder of IN8BIO, INC..
Sign up freeLoading...